Scientists discover antibodies capable of stopping several coronaviruses, potentially preventing future outbreaks

Study indicates that for some children, there is a pattern of allergy progression.

A new skin patch immunotherapy system to treat peanut allergies is being studied in toddlers and so far, it seems to work reasonably well to prevent anaphylaxis with accidental peanut ingestion.

The differences between cold symptoms and those of seasonal allergies

Researchers trying to answer the question “How immune are we?” Why answering this question is essential for post-pandemic life. The role of cellular immunity is garnering more attention.

First step studying the outcomes of a one-and-done therapy using pegylated interferon lambda demonstrated that it helped curb severe COVID-19 infection-related hospitalizations.

Quebec man with debilitating skin condition needs some compassion from the Quebec Government to cover the cost of the medication (that is working) whether or not it was vaccine-related to help him resume a normal life. But they do not seem to care.

Headline: “Scientists find potential cure for COVID-related loss of smell.” Not so fast. It concludes that greater improvement with treatment was noted compared to placebo but “there was no subjective olfactory improvement over placebo.”

Scientists discover T-cell overactivation as a key reason why long-COVID patients experience long-term smell loss

Researchers seek to understand why vaccine responses vary from person to person

Amazing study shows how natural selection due to Black Plague in the 14th Century altered subsequent population immune function

Tweaking CAR-T activity with on/off switches may reduce cytokine release syndrome.

Discovery of largely unchanged ‘weak spot’ in COVID-19 variants could lead to better treatment options

A vaccine for Lyme disease is in its Phase 3 trial. Results to date show efficacy and safety. If trial is successful, official authorization expected in 2025.

Scientists from Johns Hopkins University have genetically engineered an experimental nanobody that targets alpha-synuclein protein clumps thought to be involved in the pathophysiology of Parkinson’s disease

Brushing the tree pollen off our cars in the morning as if it is like snow and allergy sufferers are living it.

Another study confirms the safety and efficacy of peanut powder to desensitize infants and children with peanut allergy.

Small in vitro study suggests two new COVID subvariants may dodge natural immunity response. However whether this translates into worsening clinical outcomes remains unanswered.

Many Canadians continue to choose Benadryl as their first choice for allergy medication despite messaging from Canadian Society of Allergy and Clinical Immunology recommending safer 2nd and 3rd generation antihistamines.

UBC, Université de Sherbrooke, and Cornell University researchers report a new enzyme-blocking compound delivered in a nasal spray that effectively treats delta variant infection in mice. Human trials dependent on securing funding.